Clinical Trial Update: A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating mosliciguat in combination with inhaled treprostinil for pulmonary hypertension associated with interstitial lung disease; cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Pulmonary Hypertension

Drugs mentioned

• Mosliciguat (mosliciguat)
• Treprostinil (inhaled) (treprostinil)

Snippet

Sponsor: Pulmovant, Inc. | Conditions: Pulmonary Hypertension, Interstitial Lung Disease (ILD) | Phase 2 | Status: RECRUITING